Comparing Dihydrocodeine / Guaifenesin / Phenylephrine
| Dihydrocodeine / guaifenesin / phenylephrine |
|
|---|
| Dihydrocodeine / guaifenesin / phenylephrine |
|
|---|---|
|
Prescription only
Dihydrocodeine / guaifenesin / phenylephrine may also be used for purposes not listed in this medication guide. |
|
| Ratings & Reviews | |
|
Be the first to share your experience with this drug. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |
| Drug Class | |
| Generic Availability | |
|
N/A |
|
| Pricing and Coupons * Prices are without insurance | |
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | |
|
N/A |
|
| Brand Names | |
| Donatuss DC, Poly-Tussin EX Syrup | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |
|
N/A |
|
| CSA Schedule 1 View glossary of CSA terms | |
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
|
| Pregnancy Category | |
|
Category C
Risk cannot be ruled out
|
|
| Drug Interactions | |
|
A total of 668 drugs are known to interact with Dihydrocodeine / guaifenesin / phenylephrine:
|
|
| Alcohol/Food/Lifestyle Interactions | |
|
|
| Disease Interactions | |
|
|
| First Approval Date | |
|
N/A |
|
| WADA Class View classifications | |
|
N/A |
|
| More Information | |
| Patient Resources | |
|
N/A |
|
| Professional Resources | |
|
N/A |
|
| Related Treatment Guide | |
|
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.